Marin C - Search Results

1

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA. Marin C, et al. Exp Neurol. 2005 Mar;192(1):184-93. doi: 10.1016/j.expneurol.2004.10.008. Exp Neurol. 2005. PMID: 15698633

2

Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism.

Marin C, Tolosa E. Marin C, et al. Adv Neurol. 1999;80:129-33. Adv Neurol. 1999. PMID: 10410712 No abstract available.

3

Narrow beneficial effect of dextromethorphan on levodopa-induced motor response alterations in an experimental model of parkinsonism.

Jiménez A, Marin C, Bonastre M, Tolosa E. Jiménez A, et al. Among authors: marin c. Brain Res. 1999 Aug 21;839(1):190-3. doi: 10.1016/s0006-8993(99)01657-1. Brain Res. 1999. PMID: 10482813

4

Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.

Marin C, Jimenez A, Bonastre M, Chase TN, Tolosa E. Marin C, et al. Synapse. 2000 Jun 15;36(4):267-74. doi: 10.1002/(SICI)1098-2396(20000615)36:4<267::AID-SYN3>3.0.CO;2-Y. Synapse. 2000. PMID: 10819904

5

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.

Marin C, Jiménez A, Bonastre M, Vila M, Agid Y, Hirsch EC, Tolosa E. Marin C, et al. Synapse. 2001 Oct;42(1):40-7. doi: 10.1002/syn.1097. Synapse. 2001. PMID: 11668589

6

Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.

Bové J, Marin C, Bonastre M, Tolosa E. Bové J, et al. Among authors: marin c. Synapse. 2002 Dec 15;46(4):251-7. doi: 10.1002/syn.10112. Synapse. 2002. PMID: 12373740

7

Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa.

Marin C, Bové J, Bonastre M, Tolosa E. Marin C, et al. Exp Neurol. 2003 Sep;183(1):66-73. doi: 10.1016/s0014-4886(03)00107-9. Exp Neurol. 2003. PMID: 12957489

8

The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons.

Marin C, Bové J, Serrats J, Cortés R, Mengod G, Tolosa E. Marin C, et al. Exp Neurol. 2005 Jan;191(1):41-52. doi: 10.1016/j.expneurol.2004.08.033. Exp Neurol. 2005. PMID: 15589511

9

Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

Marin C, Rodriguez-Oroz MC, Obeso JA. Marin C, et al. Exp Neurol. 2006 Feb;197(2):269-74. doi: 10.1016/j.expneurol.2005.11.002. Epub 2005 Dec 22. Exp Neurol. 2006. PMID: 16375892 Review. No abstract available.

10

Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.

Bové J, Serrats J, Mengod G, Cortés R, Aguilar E, Marin C. Bové J, et al. Among authors: marin c. Synapse. 2006 Jun 1;59(7):435-44. doi: 10.1002/syn.20259. Synapse. 2006. PMID: 16498608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,019 results

Search Page

Filters